Human Coronavirus NL63 Employs the Severe Acute Respiratory Syndrome Coronavirus Receptor for Cellular Entry

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2005 May 18

PMID 15897467

Citations 485

Authors

Heike Hofmann

Krzysztof Pyrc

Lia van der Hoek

Martina Geier

Ben Berkhout

Stefan Pohlmann

Affiliations

Soon will be listed here.

Abstract

Coronavirus (CoV) infection of humans is usually not associated with severe disease. However, discovery of the severe acute respiratory syndrome (SARS) CoV revealed that highly pathogenic human CoVs (HCoVs) can evolve. The identification and characterization of new HCoVs is, therefore, an important task. Recently, a HCoV termed NL63 was discovered in patients with respiratory tract illness. Here, cell tropism and receptor usage of HCoV-NL63 were analyzed. The NL63 spike (S) protein mediated infection of different target cells compared with the closely related 229E-S protein but facilitated entry into cells known to be permissive to SARS-CoV-S-driven infection. An analysis of receptor engagement revealed that NL63-S binds angiotensin-converting enzyme (ACE) 2, the receptor for SARS-CoV, and HCoV-NL63 uses ACE2 as a receptor for infection of target cells. Potent neutralizing activity directed against NL63- but not 229E-S protein was detected in virtually all sera from patients 8 years of age or older, suggesting that HCoV-NL63 infection of humans is common and usually acquired during childhood. Here, we show that SARS-CoV shares its receptor ACE2 with HCoV-NL63. Because the two viruses differ dramatically in their ability to induce disease, analysis of HCoV-NL63 might unravel pathogenicity factors in SARS-CoV. The frequent HCoV-NL63 infection of humans suggests that highly pathogenic variants have ample opportunity to evolve, underlining the need for vaccines against HCoVs.

Citing Articles

A Comparison of Conserved Features in the Human Coronavirus Family Shows That Studies of Viruses Less Pathogenic than SARS-CoV-2, Such as HCoV-OC43, Are Good Model Systems for Elucidating Basic Mechanisms of Infection and Replication in Standard....

Heffner A, Rouault T Viruses. 2025; 17(2).

PMID: 40007010 PMC: 11860170. DOI: 10.3390/v17020256.

Autoantibodies targeting angiotensin-converting enzyme 2 are prevalent and not induced by SARS-CoV-2 infection.

Galipeau Y, Castonguay N, McCluskie P, Sonoda M, Keeshan A, Collins E FASEB J. 2025; 39(4):e70390.

PMID: 39950298 PMC: 11826374. DOI: 10.1096/fj.202402694R.

Autoantibodies in COVID-19: implications for disease severity and clinical outcomes.

Galipeau Y, Cooper C, Langlois M Front Immunol. 2025; 15():1509289.

PMID: 39835117 PMC: 11743527. DOI: 10.3389/fimmu.2024.1509289.

Transcription Kinetics in the Coronavirus Life Cycle.

Grelewska-Nowotko K, Elhag A, Turowski T Wiley Interdiscip Rev RNA. 2025; 16(1):e70000.

PMID: 39757745 PMC: 11701415. DOI: 10.1002/wrna.70000.

JN. 1 and cardiac-related clinical manifestations: a current public health concern.

Chhotaray S, Sahoo P, Mekap S, Jal S, Pattnaik G Front Cardiovasc Med. 2024; 11:1488226.

PMID: 39717444 PMC: 11663862. DOI: 10.3389/fcvm.2024.1488226.

References

Rota P, Oberste M, Monroe S, Nix W, Campagnoli R, Icenogle J . Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 2003; 300(5624):1394-9. DOI: 10.1126/science.1085952. View

Danilczyk U, Eriksson U, A Crackower M, Penninger J . A story of two ACEs. J Mol Med (Berl). 2003; 81(4):227-34. DOI: 10.1007/s00109-003-0419-x. View

Bosch B, van der Zee R, de Haan C, Rottier P . The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol. 2003; 77(16):8801-11. PMC: 167208. DOI: 10.1128/jvi.77.16.8801-8811.2003. View

Yount B, Curtis K, Fritz E, Hensley L, Jahrling P, Prentice E . Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci U S A. 2003; 100(22):12995-3000. PMC: 240733. DOI: 10.1073/pnas.1735582100. View

Li W, Moore M, Vasilieva N, Sui J, Wong S, Berne M . Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003; 426(6965):450-4. PMC: 7095016. DOI: 10.1038/nature02145. View

Peiris J, Yuen K, Osterhaus A, Stohr K . The severe acute respiratory syndrome. N Engl J Med. 2003; 349(25):2431-41. DOI: 10.1056/NEJMra032498. View

Wong S, Li W, Moore M, Choe H, Farzan M . A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J Biol Chem. 2003; 279(5):3197-201. PMC: 7982343. DOI: 10.1074/jbc.C300520200. View

Wang P, Chen J, Zheng A, Nie Y, Shi X, Wang W . Expression cloning of functional receptor used by SARS coronavirus. Biochem Biophys Res Commun. 2004; 315(2):439-44. PMC: 7111169. DOI: 10.1016/j.bbrc.2004.01.076. View

Subbarao K, McAuliffe J, Vogel L, Fahle G, Fischer S, Tatti K . Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J Virol. 2004; 78(7):3572-7. PMC: 371090. DOI: 10.1128/jvi.78.7.3572-3577.2004. View

10.

Stadler K, Masignani V, Eickmann M, Becker S, Abrignani S, Klenk H . SARS--beginning to understand a new virus. Nat Rev Microbiol. 2004; 1(3):209-18. PMC: 7097337. DOI: 10.1038/nrmicro775. View

11.

Simmons G, Reeves J, Rennekamp A, Amberg S, Piefer A, Bates P . Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc Natl Acad Sci U S A. 2004; 101(12):4240-5. PMC: 384725. DOI: 10.1073/pnas.0306446101. View

12.

van der Hoek L, Pyrc K, Jebbink M, Vermeulen-Oost W, Berkhout R, Wolthers K . Identification of a new human coronavirus. Nat Med. 2004; 10(4):368-73. PMC: 7095789. DOI: 10.1038/nm1024. View

13.

Smith A, Helenius A . How viruses enter animal cells. Science. 2004; 304(5668):237-42. DOI: 10.1126/science.1094823. View

14.

Towler P, Staker B, Prasad S, Menon S, Tang J, Parsons T . ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J Biol Chem. 2004; 279(17):17996-8007. PMC: 7980034. DOI: 10.1074/jbc.M311191200. View

15.

Fouchier R, Hartwig N, Bestebroer T, Niemeyer B, de Jong J, Simon J . A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci U S A. 2004; 101(16):6212-6. PMC: 395948. DOI: 10.1073/pnas.0400762101. View

16.

Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H . Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004; 203(2):631-7. PMC: 7167720. DOI: 10.1002/path.1570. View

17.

Yang Z, Huang Y, Ganesh L, Leung K, Kong W, Schwartz O . pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J Virol. 2004; 78(11):5642-50. PMC: 415834. DOI: 10.1128/JVI.78.11.5642-5650.2004. View

18.

Hofmann H, Hattermann K, Marzi A, Gramberg T, Geier M, Krumbiegel M . S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J Virol. 2004; 78(12):6134-42. PMC: 416513. DOI: 10.1128/JVI.78.12.6134-6142.2004. View

19.

Hofmann H, Geier M, Marzi A, Krumbiegel M, Peipp M, Fey G . Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor. Biochem Biophys Res Commun. 2004; 319(4):1216-21. PMC: 7111153. DOI: 10.1016/j.bbrc.2004.05.114. View

20.

Han D, Kim H, Kim Y, Poon L, Cho M . Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein. Virology. 2004; 326(1):140-9. PMC: 7127165. DOI: 10.1016/j.virol.2004.05.017. View